Latest News

  • Markers Of Depression Are In The Blood Of Pregnant Women

    Diagnostics World News | Perinatal depression is an understudied and underappreciated mood disorder, but a group of researchers in Michigan are moving the field forward with the discovery of predictive biomarkers of the condition that could one day be used for the routine screening of high-risk women. Nearly one in five new mothers experience severe depression and an estimated 14% have suicidal thoughts—and pregnancy itself, being a major inflammatory event, can be the inducer.

    Mar 10, 2022
  • Test Offers Personalized Prognosis Of Early-Stage Melanomas

    Diagnostics World News | Old-fashioned technology is the basis of a pioneering test that reliably predicts the spread or return of the deadliest form of skin cancer among the 20% of patients diagnosed with stage I or II melanomas that have not ulcerated. The new immunohistochemistry (IHC) test, developed by a team of scientists and clinicians at Newcastle University in the U.K., could offer relief to anxious patients as well as help shorten “ever-challenging waiting lists” for follow-up care as melanoma cases continue to rise.

    Mar 8, 2022
  • Diagnostic for PARP Inhibitor Tumor Sensitivity, New COVID Tests, Circulating Tumor DNA, More

    Diagnostics World News | Glycosaminoglycan profiling may enable all-cancer detection, maternal RNA expression profiling can predict preterm birth, Element Biosciences enters several new collaborations, and new COVID diagnostics are available.

    Mar 2, 2022
  • The Diagnostic-Therapeutic Partnership: How to Succeed, Where to Go From Here

    Diagnostics World News | During a plenary panel last week at the Molecular & Precision Med TRI-CON event, pharma and diagnostics company took on the challenges in developing companion diagnostics and how important these tests are to achieving our precision medicine aims.

    Mar 1, 2022
  • Follow the Money: AI-Powered Rapid Pathogen Diagnostics, Home-Based Male Fertility Solutions

    Diagnostics World News | Funding for virtual drug screening, AI-enhanced microscopic pathogen identification, improved genetic variant interpretation, at-home male fertility testing, single-cell sequencing technologies, and more.

    Feb 28, 2022
  • Michael Snyder on Diagnosing COVID-19 with a Smart Watch

    Diagnostics World News | Michael Snyder has been tracking his own health with extreme attention for 12 years now, gathering datapoints including his genomic data, blood markers, microbiome makeups, clinical measures, and much more. He’s found it extremely fruitful, and over the past two years, he’s applying what he’s learned to early diagnoses of COVID-19.

    Feb 25, 2022
  • Expert Panel: Next Steps to Achieving Precision Medicine

    Diagnostics World News | In the opening plenary panel for the Molecular and Precision Med Tri-Con this week, Robert Green, Brigham and Women’s Hospital, led a group in exploring how genomics, digital health, and more will converge to deliver precision health. He was joined by Megan Mahoney, Stanford University; Jessica Mega, Verily Life Sciences; Sir Mark Caulfield, Barts Life Sciences & Queen Mary University of London; and Lara Jehi, Cleveland Clinic.

    Feb 24, 2022
  • New Tools for Achieving MRD Detection, Accuracy

    Diagnostics World | On the first morning of the Molecular & Precision Med Tri-Con event, Viktor Adalsteinsson, associate director of the Gerstner Center for Cancer Diagnostics at the Broad Institute, explored new tools and techniques for detecting minimal residual disease.

    Feb 22, 2022
  • Smartphone-Based COVID-Flu Detection System Ready For Use

    Diagnostics World News | Schools, airports, and other venues where large numbers of people congregate could start using a new smartphone-based diagnostic platform that rapidly and inexpensively tests for both COVID-19 and the flu from a small volume of saliva.

    Feb 17, 2022
  • Cytokine Profiling Could Reveal Complications Of Pregnancy

    Diagnostics World News | Researchers in Norway have used cytokine profiling to create a baseline for what the immune system looks like in normal pregnancies as a starting point for discerning when something is going wrong—preeclampsia, for example. As it turns out, immune activity predictably modulates throughout uneventful pregnancies.

    Feb 15, 2022